Regadenoson .08 mg/mL (Regadenoson INJECTION, SOLUTION) .08 mg/mL

Regadenoson .08 mg/mL is a pharmaceutical injection used for specific medical imaging procedures. This solution is designed to enhance diagnostic accuracy in certain cardiovascular assessments.

Strength

.08 mg/mL

Pack Size

1 SYRINGE in 1 CARTON (10135-803-51) / 5 mL in 1 SYRINGE

Manufacturer / TM Owner

Marlex Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Regadenoson .08 mg/mL is primarily used as a pharmacological stress agent in myocardial perfusion imaging. This helps in evaluating blood flow to the heart muscle, aiding in the diagnosis of coronary artery disease. Regadenoson is often administered intravenously to simulate the effects of exercise on the heart, making it useful for patients who cannot undergo physical stress tests.

Side Effects

Regadenoson .08 mg/mL works by dilating the blood vessels in the heart, which can temporarily increase blood flow. This action helps to identify areas of the heart that may not be receiving adequate blood supply. Common effects may include shortness of breath, flushing, and headache, which typically subside quickly.

Precautions & Warnings

Regadenoson .08 mg/mL should be used with caution in patients with asthma, low blood pressure, or a history of seizures. It is important to follow the advice of a healthcare professional regarding its use. Always store the solution as directed and ensure it is used before the expiration date.

Avoid Interactions

Regadenoson .08 mg/mL may interact with certain medications, including those that affect blood pressure or heart rate. It is advisable to inform your healthcare provider about all medications you are taking before using this solution. Avoid consuming alcohol or other substances that may affect cardiovascular function.

Frequently Asked Questions

Regadenoson .08 mg/mL is used as a pharmacological stress agent in myocardial perfusion imaging to evaluate heart blood flow.

Regadenoson .08 mg/mL is administered intravenously by a healthcare professional during medical imaging procedures.

Common effects may include shortness of breath, flushing, and headache, which usually resolve quickly.

Regadenoson .08 mg/mL may interact with certain medications, so it is important to consult a healthcare provider before use.

Patients with asthma, low blood pressure, or a history of seizures should use Regadenoson .08 mg/mL with caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.